Discover research-backed methods to speed up healing after getting stitches. From optimal nutrition to proper wound care, ...

Once the CLEANVLU2 study is completed, a further Phase II study is planned over a longer period, with stratification for factors that may affect debridement and wound healing, before moving into ...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the initiation of a new Phase II clinical trial, CLEANVLU2.

BiomX announced a series of financings with total gross proceeds of approximately $12 million to support completion of Phase 2b ...

Initiated VALUE, a global Phase III pivotal trial of EscharEx® for venous leg ulcers Expanded strategic research collaborations with industry leaders, now including Kerecis $20 million in revenue for ...

The University researchers stumbled upon 2dDR’s potential while studying how the sugar could aid wound healing through the formation of new blood vessels. They observed accelerated hair growth around ...

pz-cel has the potential to be a groundbreaking therapy designed to deliver years of wound healing and pain reduction ... years after pz-cel treatment in a Phase 1/2a study, all seven participants ...

INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness ...

Brazil's health regulators have approved Telix Pharmaceuticals' nuclear imaging agent for prostate cancer, Illucix.